New cytomegalovirus-directed vaccine trial for recurrent GBM - Hallo friendsTOP POLENNEWS, In the article you read this time with the title New cytomegalovirus-directed vaccine trial for recurrent GBM, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cultur, Article economic, Article health, Article news, Article politique, Article sport, We write this you can understand. Alright, good read.

Title : New cytomegalovirus-directed vaccine trial for recurrent GBM
link : New cytomegalovirus-directed vaccine trial for recurrent GBM

New cytomegalovirus-directed vaccine trial for recurrent GBM

This phase 1 trial opened this month in New York, and will be opening in Virginia as well.

The vaccine is called VBI-1901 and consists of two CMV antigens (gB and pp65), delivered via enveloped virus-like particles (eVLP), plus GM-CSF as an adjuvant.

View trial outline here.

Thus Article New cytomegalovirus-directed vaccine trial for recurrent GBM

That's an article New cytomegalovirus-directed vaccine trial for recurrent GBM This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article New cytomegalovirus-directed vaccine trial for recurrent GBM with the link address https://polennews.blogspot.com/2017/12/new-cytomegalovirus-directed-vaccine.html

Tweet

Subscribe to receive free email updates: